Want to see CH:NWRN full AI Analyst Report?
Newron Pharmaceuticals SpA (NWRN) Income Statement
Newron Pharmaceuticals SpA Income Statement
Last quarter (Q2 2026), Newron Pharmaceuticals SpA's total revenue was $3.17M, a decrease of 6.85% from the same quarter last year. In Q2, Newron Pharmaceuticals SpA's net income was $-16.29M. See Newron Pharmaceuticals SpA’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 19.13M | $ 51.39M | $ 9.06M | $ 6.09M | $ 5.76M | |
| $ 19.13M | $ 51.39M | $ 9.06M | $ 6.09M | $ 5.76M | |
| $ 23.81M | $ 25.22M | $ 20.69M | $ 19.40M | $ 18.12M | |
| Depreciation and Amortization | $ 173.12K | $ 192.00K | $ 201.00K | $ 202.00K | $ 209.00K |
| $ -4.55M | $ 25.94M | $ -11.83M | $ -13.32M | $ -11.76M | |
| $ -4.70M | $ 26.17M | $ -11.63M | $ -13.30M | $ -12.36M | |
| $ -7.66M | $ -4.78M | $ -4.57M | $ -4.17M | $ -2.53M | |
| $ -12.35M | $ 21.39M | $ -16.20M | $ -17.47M | $ -14.88M | |
| $ -13.24M | $ 15.84M | $ -16.22M | $ -17.49M | $ -14.90M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.67 | $ 0.85 | $ -0.91 | $ -0.98 | $ -0.84 |
| Diluted EPS | $ -0.67 | $ 0.85 | $ -0.91 | $ -0.98 | $ -0.84 |
| Weighted Average Shares Outstanding | 19.96M | 18.56M | 17.84M | 17.84M | 17.84M |
| Weighted Average Shares Outstanding (Diluted) | 19.96M | 18.56M | 17.84M | 17.84M | 17.84M |
Currency in EUR